| Trial Identifier: | D7860C00003 |
| Sponsor: | AstraZeneca |
| Start Date: | May 2024 |
| Primary Completion Date: | December 2024 |
| Study Completion Date: | December 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| US, CA | Glendale, CA, US, 91206 |